Search

Byline: Gireesh Babu, New Delhi The National Pharmaceutical Pricing Authority (NPPA) has called for data from the manufacturers of specific forms of scheduled formulations of nicotine, used for nicotine replacement [...]

Byline: Gireesh Babu The National Pharmaceutical Pricing Authority (NPPA) has called for data from the manufacturers of specific forms of scheduled formulations of nicotine, used for nicotine replacement therapy, as [...]

Byline: Our Bureau The National Pharmaceutical Pricing Authority (NPPA) has approved a 50 per cent increase in ceiling prices of 11 formulations of eight drugs, invoking extraordinary powers in public [...]

Byline: Peethaambaran, Chennai The Drugs Control Administration (DCA) in Telangana has filed a case against one Himachal Pradesh based drug manufacturer under the Essential Commodities Act, 1955 for violation of [...]

The Drugs Control Administration (DCA) in Telangana has filed a case against one Himachal Pradesh based drug manufacturer under the Essential Commodities Act, 1955 for violation of Drug Price Control [...]

Byline: Our Bureau The Central government has clarified that based on the WPI factor of a positive growth of 0.00551%, there will be no change in the prevailing ceiling prices [...]

Byline: Our Bureau, New Delhi The National Pharmaceutical Pricing Authority (NPPA) has notified revised ceiling prices of 923 scheduled formulations with effect from April 1, 2024, in tune with the [...]

Byline: Our Bureau The National Pharmaceutical Pricing Authority (NPPA) has notified revised ceiling prices of 923 scheduled formulations with effect from April 1, 2024, in tune with the change in [...]

Byline: Gireesh Babu The National Pharmaceutical Pricing Authority (NPPA) has decided to use the price database from October 2023 for fixation of ceiling prices of around 225 formulations for which [...]

Byline: Gireesh Babu The National Pharmaceutical Pricing Authority (NPPA) has notified the retail price of 33 new drugs based on applications filed by the pharma companies including Sun Pharmaceuticals, Zydus [...]

Byline: Gireesh Babu The National Pharmaceutical Pricing Authority (NPPA) has notified revised ceiling price of 438 scheduled formulations in order to rectify an anomaly that took place while calculating the [...]

Byline: Gireesh Babu, New Delhi The National Pharmaceutical Pricing Authority (NPPA) has notified revised ceiling price of 438 scheduled formulations in order to rectify an anomaly that took place while [...]

Byline: Gireesh Babu The National Pharmaceutical Pricing Authority (NPPA), which has fixed the ceiling price of 651 formulations till the end of March, 2023, has said that for the rest [...]

Byline: Gireesh Babu The drug regulator has reiterated its stand on the relabelling or sticking an updated maximum retail price (MRP) on the drug packages in tune with the revised [...]

Byline: Gireesh Babu, New Delhi The Federation of Medical and Sales Representatives' Associations of India (FMRAI) has said that it will focus on launching massive campaign amongst the people for [...]

Byline: Gireesh Babu The Federation of Medical and Sales Representatives' Associations of India (FMRAI) has said that it will focus on launching massive campaign amongst the people for reduction of [...]

Byline: Gireesh Babu The National Pharmaceutical Pricing Authority (NPPA) has revised or fixed ceiling price of over 160 scheduled formulations in its latest meeting, in line with its efforts to [...]

Byline: Gireesh Babu, New Delhi The National Pharmaceutical Pricing Authority (NPPA) has revised or fixed ceiling price of over 160 scheduled formulations in its latest meeting, in line with its [...]

Byline: Nandita Vijay The Price Monitoring Resource Unit (PMRU) in Karnataka is effectively functioning to track violations of drug prices fixed by the national drug price regulator the National Pharmaceutical [...]

Byline: Gireesh Babu A proposal to regulate the prices of non-scheduled drugs, on similar lines of the previous measures to cap the prices of select anti-cancer medicines and regulate the [...]

The All Kerala Chemists and Druggists Association (AKCDA) has filed a complaint with the state drugs control department seeking an enquiry against a Kollam based pharma retail chain pharmacy firm [...]

Byline: Gireesh Babu The National Pharmaceutical Pricing Authority (NPPA) has decided to cap the prices of new scheduled drugs from the same company with significant inter-brand price variation, at the [...]

Byline: Gireesh Babu The National Pharmaceutical Pricing Authority (NPPA) has decided to cap the prices of new scheduled drugs from the same company with significant inter-brand price variation, at the [...]

Byline: Gireesh Babu, New Delhi The National Pharmaceutical Pricing Authority (NPPA) has released the draft version of calculation of ceiling prices for 45 formulations under the revised Schedule I of [...]

Byline: Gireesh Babu The National Pharmaceutical Pricing Authority (NPPA) has released the draft version of calculation of ceiling prices for 45 formulations under the revised Schedule I of the Drugs [...]

Byline: Gireesh Babu A meeting of the National Pharmaceutical Pricing Authority (NPPA) has approved the revised ceiling prices of 97 scheduled formulations as part of its efforts to fix the [...]

Byline: Gireesh Babu, New Delhi The drug price regulator has sought the pharmaceutical manufacturers and marketers to submit price details of a list of 63 formulations as part of its [...]

Byline: Gireesh Babu The drug price regulator has sought the pharmaceutical manufacturers and marketers to submit price details of a list of 63 formulations as part of its ongoing efforts [...]

Byline: Gireesh Babu The Multi Disciplinary Committee (MDC) of experts of the drug price regulator has recommended revision of the retail price of Hetero Healthcare Ltd adhesive patch of local [...]

Byline: Gireesh Babu, New Delhi The National Pharmaceutical Pricing Authority (NPPA) has finalised a framework for undertaking suo moto correction in the prices it has already notified, if it comes [...]

Byline: Gireesh Babu The National Pharmaceutical Pricing Authority (NPPA) has finalised a framework for undertaking suo moto correction in the prices it has already notified, if it comes across any [...]

Byline: Gireesh Babu, New Delhi The National Pharmaceutical Pricing Authority (NPPA) has released the fourth list of draft ceiling price calculations for 15 more drugs, as part of fixing the [...]

Byline: Gireesh Babu The National Pharmaceutical Pricing Authority (NPPA) has released the fourth list of draft ceiling price calculations for 15 more drugs, as part of fixing the ceiling prices [...]

Byline: Gireesh Babu, New Delhi The National Pharmaceutical Pricing Authority (NPPA) has released the third phase list of draft ceiling price calculations for 51 formulations, as part of fixing the [...]

Byline: Gireesh Babu The National Pharmaceutical Pricing Authority (NPPA) has released the third phase list of draft ceiling price calculations for 51 formulations, as part of fixing the ceiling prices [...]

Byline: Gireesh Babu The National Pharmaceutical Pricing Authority (NPPA) has released the second set of draft ceiling price calculations, for 43 formulations, as part of fixing the ceiling prices for [...]

Byline: Gireesh Babu, New Delhi The National Pharmaceutical Pricing Authority (NPPA) has released the second set of draft ceiling price calculations, for 43 formulations, as part of fixing the ceiling [...]

Byline: Gireesh Babu, New Delhi Almost 44 per cent of the 121 drugs for which the drug price regulator has released the draft version of calculation of ceiling prices under [...]

Byline: Gireesh Babu Almost 44 per cent of the 121 drugs for which the drug price regulator has released the draft version of calculation of ceiling prices under the revised [...]

Byline: Nandita Vijay The Karnataka State Registered Pharmacists Organisation (KSRPO) has been pushing for one formulation and one MRP (maximum retail price) to prevent anomalies in price fixation. In this [...]

Byline: Our Bureau The National Pharmaceutical Pricing Authority (NPPA) has so far fixed ceiling prices of 890 scheduled formulations and retail price of around 2,023 new drugs, among others, said [...]

Byline: Laxmi Yadav The SME Pharma Industries-Confederation (SPIC), a body of thousands of small-scale pharma units in the country has appealed to the department of pharmaceuticals (DoP) to reduce prices [...]

Byline: Peethaambaran Kunnathoor Fully supporting the demand raised by the All Kerala Chemists and Druggists Association (AKCDA) that Union government must issue an order to ban display of signboards put [...]

Byline: Gireesh Babu The Department related Parliamentary Standing Committee for the Ministry of Chemicals and Fertilisers has further pushed its earlier recommendation to the Department of Pharmaceuticals (DoP) for a [...]

Byline: Nandita Vijay India's Universal Health Care (UHC) thrives on assured quality of essential medicine and its prioritization. The government and the industry are now working to obtain best quality [...]

Byline: Laxmi Yadav The Indian Drug Manufacturers' Association (IDMA) has urged Mansukh Mandaviya, Union minister of health and family welfare and chemicals and fertilizers to permit the drug makers to [...]

Byline: Gireesh Babu The drug price regulator has refused pharma major Cipla Ltd's application to discontinue four of its formulations to treat Human Immunodeficiency Virus (HIV), noting that it may [...]